26Jun 2023
A triple dose of optimism: an initial foray into triplet therapy in metastatic renal cell carcinoma

A triple dose of optimism: an initial foray into triplet therapy in metastatic renal cell carcinoma

The COSMIC-313 study has developed a triplet regimen that incorporates all approved drugs targeting actionable targets in renal cell carcinoma. While this approach demonstrates higher clinical effectiveness compared to one of the standard doublet therapies, the potential for toxicities may restrict the proper administration of the drugs. Therefore, the study advises against the immediate adoption of this regimen.

  • #oncology

Like

Save

Share